The Optical Biopsy Blog - Mauna Kea Technologies' Official Corporate Blog

Building Consensus as the International Community of Cellvizio Users Expands

Posted by Sacha Loiseau, Ph.D., President and CEO

Find me on:

June 25, 2014 at 4:44 AM

In any discipline, and particularly in the field of medicine, change takes time. Advanced technology that disrupts the traditional way of doing things requires early adopters who see value and are eager to share the potential with their peers. As technology becomes more accessible, a large community is formed that carries significant weight in advocacy and in practice. That is the case for Cellvizio and the future of Optical Biopsy.

One important step for the continued growth of the Cellvizio community is implementation into clinical practice guidelines. Leading organizations including the American Society for Gastrointestinal Endoscopy often consider updating guidelines when a large scientific community agrees new technology has proven benefits. For example, at Digestive Disease Week 2014 a group of 26 physicians presented consensus statements supporting confocal laser endomicroscopy use in barrett's esophagus and biliary strictures, and also discussed how to implement training and credentialing in hospitals.

Programs for connecting with new physicians and providing educational tools and trainings will help nurture the community of Cellvizio users as well. More than 260 physicians from 30 countries around the world recently convened for the International Conference of Cellvizio Users (ICCU) in Opio, France to share findings in Cellvizio clinical use and discuss the future for Optical Biopsy.

ICCU was created to foster collaboration across countries and specialties including pre-clinical and clinical users, laying out a roadmap for potential applications in gastroenterology, urology, pulmonology, pathology, surgery, and other specialties.

The Cellvizio community convenes for ICCU annually, but we also continue to engage physicians throughout the year with a full credentialing program on, an educational platform providing content on how to use Cellvizio and how to interpret its microscopic images in gastroenterology, pulmonology and urology applications. Institutional training courses for both new adopters and experienced Cellvizio users are now available in several countries including France, Russia, Brazil, and China.

Engaging the scientific community and building consensus will continue to be our focus in the years ahead as the established international community of Cellvizio users expands its influence with conference presentations, society representation, and high-impact publications. Remember, if you have a comment about a topic we cover in a post, or have a suggestion for a future blog post topic, we want to hear from you. Visit our Twitter handle @maunakeatech or click here to contact us. You can also find me on my personal account @sachaloiseau.


Cellvizio, Mauna Kea Technologies, Optical Biopsy

Topics: Mauna Kea Technologies, Company news, Optical Biopsy


About this blog

The latest news and information about Mauna Kea Technologies and Cellvizio Optical Biopsy, the Fastest Way to See Cancer. 

Subscribe to Email Updates